Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.22.1
Summary of Significant Accounting Policies (Details) - shares
3 Months Ended 10 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Stock Options [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from computation of diluted net loss per share 2,906,948 489,255  
Stock Options [Member] | Merger agreement      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common stock issued (in shares)     516,025
Stock Options [Member] | Merger agreement | GEM Warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from computation of diluted net loss per share     1,044,453
Common stock warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from computation of diluted net loss per share 17,521,753 1,200,307  
Earnout Shares      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from computation of diluted net loss per share 22,209,280    
Earnout Shares | Merger agreement      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from computation of diluted net loss per share     185,472
Earnout Shares from exercised Substitute Options and Substitute Warrants      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Shares excluded from computation of diluted net loss per share 1,229,925